FDA Clearance Tracker · P000043-S016
THERMATRX OFFICE THERMO THERAPY
Last checked: Nov 20, 2026Latest source record: Oct 13, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Oct 13, 2006
Approved
Time to decision
21 days
Received Sep 22, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P000043-S016
- Device name
- THERMATRX OFFICE THERMO THERAPY
- Applicant
- Boston Scientific Corp
- Applicant location
- Marlboro, MA
- Received
- Sep 22, 2006
- Decided
- Oct 13, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P000043
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT MRI MANUFACTURING AND RESEARCH, INC., TUCSON, ARIZONA TO CONDUCT PACKAGING AND LABELING FOR THE RX-200 APPLICATOR (CATHETER).
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.